BLUE DOC LIMITEDActive

Company number 10071562Private limited companyIncorporated 2016

Key figures

−£6,755-24.8%
Net assets 2024/25
-8 k-6 k-4 k-2 k02020/212021/222022/232023/242024/25

Like most small UK companies, BLUE DOC LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
02.5 k5 k7.5 k2020/212021/222022/232023/242024/25
Filed accounts2020/21–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand171169———
Total assets510252250154103
Total liabilities1,8842,9764,2045,4476,738
Net assets / total equity-1,374-2,724-4,074-5,413-6,755
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

The principal activity of the company during the year under review was specialists medical practice activities.

As described in the company's latest filed accounts.

Summary: BLUE DOC LIMITED

Company

BLUE DOC LIMITED is a private limited company registered with Companies House under company number 10071562. It was incorporated on 18 Mar 2016. Its status is active. The registered office is in Milton keynes (MK2). Its nature of business (SIC 2007) is specialists medical practice activities (86220).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files micro-entity accounts. Net assets were −£6,755, down 24.8% on the previous year. Total assets were £103 and total liabilities £6,738. The company had an average of 1 employee. Figures are available for 5 financial years (2020/21–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 18 Feb 2027.